Top 5 Blue Chip Stocks To Buy For 2014

Why are markets going to keep going up? �

Because as long as the easy money party being put on by the central banks globally lasts they have to.

At least that is what Jim Rogers thinks.

He also warns that at some point in time that party has to stop. �When it does it is going to get ugly.

One market Jim Rogers would favor is Japan, specifically its blue chip companies. �New taxation policies in Japan have made stocks very attractive for Japanese citizens.

If you are interested in investing for the long term you should consider investing where the Chinese government will be investing which is in railroads and other things that will address China's pollution.

About the author:Canadian Valuehttp://valueinvestorcanada.blogspot.com/
Currently 1.50/512345

Rating: 1.5/5 (2 votes)

Top 5 Defensive Companies To Buy For 2015: Colgate-Palmolive Company(CL)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and markets consumer products worldwide. It offers oral care products, including toothpaste, toothbrushes, and mouth rinses, as well as dental floss and pharmaceutical products for dentists and other oral health professionals; personal care products, such as liquid hand soap, shower gels, bar soaps, deodorants, antiperspirants, shampoos, and conditioners; and home care products comprising laundry and dishwashing detergents, fabric conditioners, household cleaners, bleaches, dishwashing liquids, and oil soaps. The company offers its oral, personal, and home care products under the Colgate Total, Colgate Max Fresh, Colgate 360 Advisors' Opinion:

• [By James Well]

  Analysts��Consensus Position on Pfizer
  
  Thirteen analysts including those at TheStreet, Thomson Reuters/Verus, Goldman Sachs, J.P. Morgan, Barclays Capital, Morgan Stanley and Argus Research are optimistic about the performance of Pfizer going forward and, hence, reiterated a consensus buy recommendation at an average target price of $31.78 per share. Last Wednesday, analysts at Goldman Sachs removed Pfizer from Goldman�� conviction buy list (CL) where Pfizer has been since Aug. 9, 2011, and placed it on the buy list but raised its price target from $34 to $35 per share. Jami Rubin, an analyst with Goldman Sachs, claimed that Pfizer has gone up by 82.5% since being added to the CL as against 53.9% for the S&P 500 during the period and, therefore, there was the need to replace Pfizer with AbbVie at a price target of $60 because they claimed AbbVie has greater upside at this time.

• [By TaniaC]

  Colgate-Palmolive Company (CL) is a consumer products company whose products are marketed in over 200 countries and territories throughout the world. It operates in two segments: Oral, Personal and Home Care and Pet Nutrition.

• [By Dan Caplinger]

  Lately, Johnson & Johnson has presented two different faces to investors. On one hand, the company has faced the challenge of dealing with a weak consumer-products business, as multiple recalls and close regulatory oversight of its production facilities have exacerbated J&J's problems. With its more focused consumer-goods business, Colgate-Palmolive (NYSE: CL  ) has worked harder at taking advantage of international growth opportunities than many of its rivals, and Colgate's strong overseas sales, in comparison to J&J's international weakness, show the effectiveness of that strategy. In particular, Asia has been a focus point for Colgate, with revenue from the region having risen 9% year over year compared with less than 3% growth overall. Moreover, Latin America represents Colgate's biggest region for sales, with more than half again the revenue its U.S. segment produces.

• [By Dan Caplinger]

  One concern, though, is how the company handled news of Venezuela's currency devaluation. Clorox (NYSE: CLX  ) and Colgate-Palmolive (NYSE: CL  ) also felt the pinch, with Clorox taking about a $0.05 to $0.10 per-share earnings hit and Colgate losing about $0.50 per share. But they also addressed the potential devaluation more proactively than P&G did. Clorox actually�anticipated�the devaluation in its February earnings report, projecting the potential hit if a devaluation took place. Colgate didn't provide specific guidance in advance but clearly saw it as an issue, delivering on a promise to give prompt guidance revisions after the devaluation occurred.

Top 5 Blue Chip Stocks To Buy For 2014: Visa Inc.(V)

Visa Inc., a payments technology company, engages in the operation of retail electronic payments network worldwide. It facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. The company owns and operates VisaNet, a global processing platform that provides transaction processing services. It also offers a range of payments platforms, which enable credit, charge, deferred debit, debit, and prepaid payments, as well as cash access for consumers, businesses, and government entities. The company provides its payment platforms under the Visa, Visa Electron, PLUS, and Interlink brand names. In addition, it offers value-added services, including risk management, issuer processing, loyalty, dispute management, value-added information, and CyberSource-branded services. The company is headquartered in San Francisco, California.

Advisors' Opinion:

• [By Victor Reklaitis]

  The Dow Jones Industrial Average (DJIA) rose 71 points, or 0.5%, to 15,067. Visa Inc. (V) �showed the largest gain among blue chips with its 1% advance, while Verizon Communications Inc. (VZ) � and Merck & Co. (MRK) �were the biggest losers as they each fell 0.6%.

• [By Ben Levisohn]

  The Dow was weighed down by Nike, which fell 3% to $76.84 ahead of next week’s earnings, while United Health dropped 2.6% to $72.14 and Pfizer declined 2.2% to $30.65. Only five Dow components finished in the green, including Visa (V), which rose 3.1% to $205.66 after Mastercard’s (MA) big dividend/buyback/stock-slit announcement.

• [By Charley Blaine]

  But keep this in mind: Thirteen of the 30 Dow stocks are still ahead on the year, led by Merck (NYSE: MRK) and Caterpillar (NYSE: CAT), both up about 11.7 percent. Goldman Sachs (NYSE: GS), Visa (NYSE: V) and aerospace giant Boeing (NYSE: BA) are the laggards -- down 13.8 percent, 11.7 percent and 10.6 percent, respectively. More than 230 S&P 500 stocks are still ahead on the year.

Top 5 Blue Chip Stocks To Buy For 2014: Chevron Corporation(CVX)

Chevron Corporation, through its subsidiaries, engages in petroleum, chemicals, mining, power generation, and energy operations worldwide. It operates in two segments, Upstream and Downstream. The Upstream segment involves in the exploration, development, and production of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as holds interest in a gas-to-liquids project. The Downstream segment engages in the refining of crude oil into petroleum products; marketing of crude oil and refined products primarily under the Chevron, Texaco, and Caltex brand names; transportation of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car; and manufacture and marketing of commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives. It a lso produces and markets coal and molybdenum; and holds interests in 13 power assets with a total operating capacity of approximately 3,100 megawatts, as well as involves in cash management and debt financing activities, insurance operations, real estate activities, energy services, and alternative fuels and technology business. Chevron Corporation has a joint venture agreement with China National Petroleum Corporation. The company was formerly known as ChevronTexaco Corp. and changed its name to Chevron Corporation in May 2005. Chevron Corporation was founded in 1879 and is based in San Ramon, California.

Advisors' Opinion:

• [By Anders Bylund]

  Exxon is a bit of an anomaly, as the company manages to stick close to the Dow average here, dishing out 45.7% of its free cash, while the broader oil industry tends to jump around at the whim of changing petroleum prices. Fellow oil-producer Chevron (NYSE: CVX  ) isn't so lucky, spending 86% of its free cash on dividend checks. The roles were the same a year earlier, though the magnitudes were different: Chevron invested 41.8% of its 2011 cash flow in dividends, while Exxon's ratio was an even lower 37%.

• [By Ben Levisohn]

  Howard Weil’s Blake Fernandez�explains why he prefers ConocoPhillips to�other oil companies like Total (TOT) and�Chevron�(CVX):

  After years of portfolio rationalization, concerns re: dividend coverage, etc. the asset base is now poised to deliver 6- 10% cash flow CAGR through ��7 from a combination of 3-5% production growth and 3-5% margin expansion. Additionally, our confidence in the Company�� unconventional prowess is increasing based on the recent analyst day presentation, higher production targets and efficiency gains in the underlying assets…

• [By Claudia Assis]

  Chevron (CVX) �shares ended 1.6% lower, the worst-performing stock on the Dow Jones Industrial Average.

Top 5 Blue Chip Stocks To Buy For 2014: Philip Morris International Inc(PM)

Philip Morris International Inc., through its subsidiaries, engages in the manufacture and sale of cigarettes and other tobacco products in markets outside of the United States. Its international product brand line comprises Marlboro, Merit, Parliament, Virginia Slims, L&M, Chesterfield, Bond Street, Lark, Muratti, Next, Philip Morris, and Red & White. The company also offers its products under the A Mild, Dji Sam Soe, and A Hijau in Indonesia; Diana in Italy; Optima and Apollo-Soyuz in the Russian Federation; Morven Gold in Pakistan; Boston in Colombia; Belmont, Canadian Classics, and Number 7 in Canada; Best and Classic in Serbia; f6 in Germany; Delicados in Mexico; Assos in Greece; and Petra in the Czech Republic and Slovakia. It operates primarily in the European Union, Eastern Europe, the Middle East, Africa, Asia, Canada, and Latin America. The company is based in New York, New York.

Advisors' Opinion:

• [By Jonas Elmerraji]

  As the world's second largest tobacco company, Philip Morris International (PM) is the prototypical sin stock. It boasts recognizable brands, a sticky customer base, and a hefty dividend payout -- and the payout looks due for a dividend hike. As I write, Philip Morris International currently pays out a 85 cents each quarter, adding up to a 4.05% yield.

  Philip Morris owns almost 30% of the world's tobacco market. And much of that success is thanks to a single iconic brand: Marlboro. The firm has owned Marlboro (as well as second-tier names such as L&M and Parliament) internationally ever since Altria (MO) split up its international and domestic operations. Between the two markets, PM owns the more attractive franchise by far. After all, the international market is the only one that's actually growing.

  While the U.S. market for tobacco products is rife with regulation and demographic shifts are turning away from smoking, international tobacco sales are up -- especially in emerging markets. Premium positioning in markets like India, China and Indonesia translates into substantial cash flows for PM investors. And while the strength of the dollar has been a challenge post-2008, the potential for a Fed taper could strengthen this stock's payout in 2013.

• [By Laura Brodbeck]

  Thursday

  Earnings Expected From: Credit Suisse Group (NYSE: CS), Expedia Inc. (NASDAQ: EXPE), Kellogg Company (NYSE: K), LinkedIn Corporation (NYSE: LNKD), Philip Morris International Inc. (NYSE: PM) Economic Releases Expected: French trade balance, British trade balance, eurozone consumer confidence, German industrial production, Bank of England interest rate decision, European Central Bank interest rate decision, US initial and continuing jobless claims, Chinese trade balance

  Friday